BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 19199937)

  • 1. Natural killer T cells and autoimmune disease.
    Wu L; Van Kaer L
    Curr Mol Med; 2009 Feb; 9(1):4-14. PubMed ID: 19199937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cells as targets for immunotherapy of autoimmune diseases.
    Van Kaer L
    Immunol Cell Biol; 2004 Jun; 82(3):315-22. PubMed ID: 15186263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.
    Wilson MT; Van Kaer L
    Curr Pharm Des; 2003; 9(3):201-20. PubMed ID: 12570826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells and autoimmune diseases: unraveling the complexity.
    Miyake S; Yamamura T
    Curr Top Microbiol Immunol; 2007; 314():251-67. PubMed ID: 17593664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
    Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
    Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune regulation by invariant NKT cells in autoimmunity.
    Ronchi F; Falcone M
    Front Biosci; 2008 May; 13():4827-37. PubMed ID: 18508548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
    Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
    J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.
    Miyake S; Yamamura T
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of regulation of autoimmunity by iNKT cells.
    Novak J; Lehuen A
    Cytokine; 2011 Mar; 53(3):263-70. PubMed ID: 21185200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer T cells in health and disease.
    Wu L; Van Kaer L
    Front Biosci (Schol Ed); 2011 Jan; 3(1):236-51. PubMed ID: 21196373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
    Simoni Y; Diana J; Ghazarian L; Beaudoin L; Lehuen A
    Clin Exp Immunol; 2013 Jan; 171(1):8-19. PubMed ID: 23199318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of natural killer T (NKT) cells in the pathogenesis of type 1 diabetes.
    Gómez-Díaz RA; Aguilar MV; Meguro EN; Márquez RH; Magaña EG; Martinez-García MC; Rodarte NW; Aguilar-Salinas CA; Canché-Pool E; Ortiz-Navarrete V
    Curr Diabetes Rev; 2011 Jul; 7(4):278-83. PubMed ID: 21644914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.